India to Canada: Spironolactone Export Trade Route

The India to Canada Spironolactone corridor is one of India's established pharmaceutical export routes, with 46 shipments documented worth a combined $2.0M USD. The route is dominated by COHANCE LIFESCIENCES LIMITED, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's spironolactone manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $43.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with spironolactone's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 22.3%, placing it at rank #16 among India's top spironolactone export destinations globally.

On the import side, key buyers of Indian spironolactone in Canada include MINT PHARMACEUTICALS INC, MINT PHARMACEUTICALS INC , JAMP PHARMA CORP. and 5 others. MINT PHARMACEUTICALS INC is the single largest importer with 21 shipments valued at $1.0M USD.

India's spironolactone exports to Canada are driven primarily by a handful of large-scale manufacturers. COHANCE LIFESCIENCES LIMITED with 24 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — COHANCE LIFESCIENCES LIMITED, GRACURE PHARMACEUTICALS LIMITED , COHANCE LIFESCIENCES LIMITED — together account for 90% of total trade value on this route. The average shipment value of $43.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as spironolactone tablets usp 25mg (500s-count) and spironolactone tablets usp 25mg 12201 bottles of 500 s 6100500 tabs, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MINT PHARMACEUTICALS INC is the largest importer with 21 shipments worth $1.0M USD — representing 51% of all spironolactone imports from India on this route. A total of 8 buyers are active on this corridor.